Business
Bill Gates Has 5 Book Recommendations For Your 2021 Holiday Season
November 23, 2021
February 19, 2022
Bill Gates said Friday that the risks of severe disease from Covid-19 have “dramatically reduced” but another pandemic is all but certain.
Gates, co-chair of the Bill & Melinda Gates Foundation, said that a potential new pandemic would likely stem from a different pathogen to that of the coronavirus family.
“We’ll have another pandemic. It will be a different pathogen next time,” Gates said.
Two years into the coronavirus pandemic, Gates said the worst effects have faded as huge swathes of the global population have gained some level of immunity. Its severity has also waned with the latest omicron variant.
“The chance of severe disease, which is mainly associated with being elderly and having obesity or diabetes, those risks are now dramatically reduced because of that infection exposure,” he said.
The world needs to move faster against infections
Gates said it was already “too late” to reach the World Health Organization’s goal to vaccinate 70% of the global population by mid-2022. Currently, 61.9% of the world population has received at least one dose of a Covid-19 vaccine.
He added that the world should move faster in the future to develop and distribute vaccines, calling on governments to invest now.
“Next time we should try and make it, instead of two years, we should make it more like six months,” Gates said, adding that standardized platforms, including messenger RNA (mRNA) technology, would make that possible.
“The cost of being ready for the next pandemic is not that large. It’s not like climate change. If we’re rational, yes, the next time we’ll catch it early.”
Gates, through the Bill & Melinda Gates Foundation, has partnered with the U.K.’s Wellcome Trust to donate $300 million to the Coalition for Epidemic Preparedness Innovations, which helped form the Covax program to deliver vaccines to low- and middle-income countries.
The CEPI is aiming to raise $3.5 billion in an effort to cut the time required to develop a new vaccine to just 100 days.